Yeah, it's very hard to estimate. I would imagine AMBS would likely go for a deal structure with more cash and les royalty just based on where they are as a company. I would think the cash helps them find more assets and develop current assets to get them to the same stage. I may be wrong though.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links